Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the combination of cemiplimab and fianlimab in people with clear cell renal …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma [Phase 1, Phase 2]
A phase 1/2 study evaluating CAR.70-engineered IL-15-transduced cord blood-derived NK cells with lymphodepleting chemotherapy for advanced r…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) [Phase 1, Phase 2]
Genmab's PRO1160 (GEN1160) Phase 1/2 trial in relapsed or refractory non-Hodgkin lymphoma has been terminated; the study also included renal…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies [Phase 1]
Phase 1 trial evaluating DFF332 as a single agent and in combination with Everolimus and immuno-oncology agents in advanced/relapsed renal c…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers [Phase 1]
Nuvectis Pharma reports a Phase 1 clinical trial of NXP-900 in subjects with advanced cancers is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Occupational Situation and Return to Work of Urological Patients
A clinical trial from Jagiellonian University is evaluating return-to-work and occupational outcomes in urological cancer patients. The stud…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]
This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer [Phase 1]
This update describes an ongoing Phase 1 trial evaluating interstitial brachytherapy for unresectable renal cell carcinoma (kidney cancer). …
-
EMA approval · 2026-02-27EMA Authorised: Cabometyx (cabozantinib (s)-malate) — Ipsen Pharma
The EMA authorised Cabometyx (cabozantinib (s)-malate) for renal cell carcinoma and hepatocellular carcinoma in the EU, with Ipsen Pharma as…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting
A completed real-world study evaluated how second-line axitinib (Inlyta) impacts outcomes for patients with metastatic renal cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Circulating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney Cancer [NA]
A completed clinical trial evaluates circulating and urinary exosomal microRNA as predictors of treatment response in advanced renal cell ca…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Lu-177 PSMA Treatment in Cell Renal Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating Lu-177 PSMA therapy for metastatic renal cell carcinoma is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pazopanib hydrochloride in combination with bevacizumab for previously untreated metastatic renal cell…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer [Phase 1]
Phase 1 clinical trial evaluating nivolumab and ipilimumab, with or without the EXL01 live biotherapeutic product, for metastatic renal cell…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
A Mayo Clinic-led clinical trial is evaluating whether tumor-derived extracellular vesicles can noninvasively classify different kidney canc…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer-sponsored trial evaluating first- and later-line therapies for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Video Education With Result Dependent dIsclosure [NA]
A Dana-Farber Cancer Institute clinical trial update for a study on video education with result-dependent disclosure, currently recruiting, …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: 177LuPSMA in Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating Lutetium-177 labeled PSMA radioligand (177Lu-PSMA) in advanced renal cell carcinoma. The study is currently active …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors [Phase 2]
A Phase 2 clinical trial is evaluating hyperpolarized 13C pyruvate MRI as a biomarker to predict aggressiveness of renal tumors. The study i…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. [Phase 1]
Phase 1 study of PF-07826390 in cancer patients, including non-small cell lung cancer, was terminated; the trial evaluated different doses o…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 imaging trial evaluating 89Zr-DFO-Atezolizumab with PET/CT in locally advanced or metastatic renal cell carcinoma is currently recru…
-
CLINICAL_TRIALS withdrawal · 2026-02-17Clinical Trial Update: Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC) [Phase 2]
A Phase 2 trial evaluating acarbose in combination with standard therapy for metastatic renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma [Phase 2]
Phase II trial evaluating a combination of anti-PD-1 therapy and aldesleukin (IL-2) for metastatic melanoma and metastatic renal cell carcin…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation [Phase 2]
A Phase 2 clinical trial evaluating contrast-enhanced ultrasound imaging to diagnose recurrent renal cell carcinoma after ablation is curren…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of intravenous QEQ278 in patients with advanced solid tumors has been terminated.